Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 28:7:12.
doi: 10.3389/fimmu.2016.00012. eCollection 2016.

Animal Models for HIV Cure Research

Affiliations
Review

Animal Models for HIV Cure Research

Benjamin B Policicchio et al. Front Immunol. .

Abstract

The HIV-1/AIDS pandemic continues to spread unabated worldwide, and no vaccine exists within our grasp. Effective antiretroviral therapy (ART) has been developed, but ART cannot clear the virus from the infected patient. A cure for HIV-1 is badly needed to stop both the spread of the virus in human populations and disease progression in infected individuals. A safe and effective cure strategy for human immunodeficiency virus (HIV) infection will require multiple tools, and appropriate animal models are tools that are central to cure research. An ideal animal model should recapitulate the essential aspects of HIV pathogenesis and associated immune responses, while permitting invasive studies, thus allowing a thorough evaluation of strategies aimed at reducing the size of the reservoir (functional cure) or eliminating the reservoir altogether (sterilizing cure). Since there is no perfect animal model for cure research, multiple models have been tailored and tested to address specific quintessential questions of virus persistence and eradication. The development of new non-human primate and mouse models, along with a certain interest in the feline model, has the potential to fuel cure research. In this review, we highlight the major animal models currently utilized for cure research and the contributions of each model to this goal.

Keywords: FIV; HIV; SIV; animal models; cure; humanized mice; non-human primates; viral reservoir.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, Chomont N, et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol (2012) 12(8):607–14.10.1038/nri3262 - DOI - PMC - PubMed
    1. Hogg R, Lima V, Sterne J, Grabar S, Battegay M, Monforte A, et al. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet (2008) 372(9635):293–9.10.1016/S0140-6736(08)61113-7 - DOI - PMC - PubMed
    1. Shen L, Siliciano RF. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J Allergy Clin Immunol (2008) 122(1):22–8.10.1016/j.jaci.2008.05.033 - DOI - PMC - PubMed
    1. Pomerantz RJ, Zhang H. Residual HIV-1 persistence during suppressive HAART. Curr Clin Top Infect Dis (2001) 21:1–30. - PubMed
    1. Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med (2009) 15(8):893–900.10.1038/nm.1972 - DOI - PMC - PubMed

LinkOut - more resources